Allergan plc:企業の戦略・SWOT・財務情報

◆英語タイトル:Allergan plc - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C14155
◆発行会社(調査会社):MarketLine
◆発行日:2019年3月
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Allergan plc – Strategy, SWOT and Corporate Finance Report
Summary

Allergan plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Allergan plc (Allergan or ‘the company’) is a pharmaceutical company that develops, manufactures and markets branded pharmaceutical products, biologic, device, surgical and regenerative medicine products. The company offers products in various therapeutic areas, including central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories. Allergan sells its brand and aesthetic products to drug wholesalers, retailers and distributors, including national retail drug and food store chains, hospitals, clinics, mail order retailers, government agencies and managed healthcare providers such as health maintenance organizations and other institutions. It has business presence in the US, Europe, Asia and other regions of the world. The company is headquartered in Dublin, Ireland.

Scope

- Detailed information on Allergan plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Allergan plc in the form of a SWOT analysis
- An in-depth view of the business model of Allergan plc including a breakdown and examination of key business segments
- Intelligence on Allergan plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Allergan plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Allergan plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Allergan plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Allergan plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Allergan plc: Company Overview
Allergan plc: Overview and Key Facts
Allergan plc: Overview
Allergan plc: Key Facts
Allergan plc: Key Employees
Allergan plc: Key Employee Biographies
Allergan plc: Major Products and Services
Allergan plc: Company History
Allergan plc: Management Statement
Allergan plc: Key Competitors
Allergan plc: Company Analysis
Allergan plc: Business Description
Allergan plc: SWOT Analysis
Allergan plc: SWOT Overview
Allergan plc: Strengths
Allergan plc: Weaknesses
Allergan plc: Opportunities
Allergan plc: Threats
Allergan plc: Corporate Financial Deals Activity
Allergan plc: Financial Deals Overview
Allergan plc: Targets and Partners
Allergan plc: Top Deals 2015 – 2019YTD*
Allergan plc: Advisors
Allergan plc: Top Legal Advisors
Allergan plc: Top Financial Advisors
Allergan plc: Mergers and Acquisitions
Allergan plc: Capital Raising
Allergan plc: Partnership
Allergan plc: Divestments
Allergan plc: Private Equity and Ownership
Allergan plc: Recent Developments
Allergan plc: News and Events Summary
Allergan plc: Business Expansion
Allergan plc: Corporate Governance
Allergan plc: Market Developments
Allergan plc: Red Flags/DistressSignals
Allergan plc: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Allergan plc: Key Facts
Table 2: Allergan plc: Key Employees
Table 3: Allergan plc: Company History
Table 4: Allergan plc: Key Competitors
Table 5: Allergan plc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Allergan plc: M&A Activity by Geography (TTM*)
Table 7: Allergan plc: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Allergan plc: M&A Average Deal Size - Value (US$m)
Table 9: Allergan plc: Targets and Partners
Table 10: Allergan plc: Top Deals 2015 - 2019YTD*
Table 11: Allergan plc: Legal Advisor Ranking by Value (US$m)
Table 12: Allergan plc: Financial Advisor Ranking by Value (US$m)
Table 13: Allergan plc: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: Allergan plc: M&A Activity by Geography (2015 - YTD*2019)
Table 15: Allergan plc: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 16: Allergan plc: Capital Raising by Deal Type (2015 - YTD*2019)
Table 17: Allergan plc: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 18: Allergan plc: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 19: Allergan plc: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 20: Allergan plc: Divestments by Geography (2015 - YTD*2019)
Table 21: Allergan plc: Private Equity and Ownership Volume and Value Trend (2015 - YTD*2019)
Table 22: Allergan plc: Private Equity and Ownership Volume by Deal Type (2015 - YTD*2019)
Table 23: Allergan plc: News and Events Summary
Table 24: Allergan plc: Business Expansion
Table 25: Allergan plc: Corporate Governance
Table 26: Allergan plc: Market Developments
Table 27: Allergan plc: Red Flags/DistressSignals
Table 28: Allergan plc: Strategy and Operations

List of Figures
Figure 1: Allergan plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Allergan plc: M&A Activity by Geography (TTM*)
Figure 3: Allergan plc: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 4: Allergan plc: M&A Average Deal Size - Value (US$m)
Figure 5: Allergan plc: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 6: Allergan plc: M&A Activity by Geography (2015 - YTD*2019)
Figure 7: Allergan plc: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 8: Allergan plc: Capital Raising by Deal Type (2015 - YTD*2019)
Figure 9: Allergan plc: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 10: Allergan plc: Partnership Trend by Deal Type (2015 - YTD*2019)
Figure 11: Allergan plc: Divestments Volume and Value Trend (2015 - YTD*2019)
Figure 12: Allergan plc: Divestments by Geography (2015 - YTD*2019)
Figure 13: Allergan plc: Private Equity and Ownership Volume and Value Trend (2015 - YTD*2019)
Figure 14: Allergan plc: Private Equity and Ownership Volume by Deal Type (2015 - YTD*2019)

★海外企業調査レポート[Allergan plc:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • People’s Bank:企業の戦略・SWOT・財務情報
    People's Bank - Strategy, SWOT and Corporate Finance Report Summary People's Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • MannKind Corp (MNKD):製薬・医療:M&Aディール及び事業提携情報
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high …
  • Biofuels Power Corp (BFLS):企業の財務・戦略的SWOT分析
    Summary Biofuels Power Corp (BFLS), is a renewable energy corporation that develops bio fuels. The corporation operates and develops grid-connected biodiesel power electric generation plants. It produces fuels through transesterification of off-spec oils and gasification of waste products such as gl …
  • SK Innovation Co Ltd (096770):石油・ガス:M&Aディール及び事業提携情報
    Summary SK Innovation Co Ltd (SK Innovation) is an integrated energy and petrochemical company. It explores for and produces crude oil and natural gas; transportation of crude oil; and production of oil products such as gasoline and diesel. Through subsidiaries, the company carries out refining oper …
  • Orsted Salg & Service AS:企業の戦略的SWOT分析
    Orsted Salg & Service AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Brown-Forman Corporation:戦略・SWOT・企業財務分析
    Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report Summary Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • John Keells Holdings PLC (JKH.N0000):企業の財務・戦略的SWOT分析
    Summary John Keells Holdings PLC (John Keells) is a business and consumer services company that provides hotel management services. The company offers services such as airline and aviation services, cinnamon hotels and resorts services, holiday and tour consulting services, port and marine fuel serv …
  • Aegean Marine Petroleum Network Inc (ANW):企業の財務・戦略的SWOT分析
    Aegean Marine Petroleum Network Inc (ANW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Regen BioPharma Inc (RGBP):企業の財務・戦略的SWOT分析
    Summary Regen BioPharma Inc (Regen BioPharma), a subsidiary of Bio-Matrix Scientific Group Inc, is an immunology and immunotherapy space provider. The company concentrates on the development of immunotherapies and cancer stem cell therapies. Its product pipeline includes HemaXellerate, dCellVax, Dif …
  • Hokkaido Electric Power Co., Inc.:企業の戦略・SWOT・財務分析
    Hokkaido Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Hokkaido Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Bega Cheese Ltd:企業のM&A・事業提携・投資動向
    Bega Cheese Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bega Cheese Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Woori Bank:企業の戦略・SWOT・財務情報
    Woori Bank - Strategy, SWOT and Corporate Finance Report Summary Woori Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Dining Street Ltd:企業の戦略・SWOT・財務分析
    Dining Street Ltd - Strategy, SWOT and Corporate Finance Report Summary Dining Street Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Okklo Life Sciences BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Okklo Life Sciences BV (Okklo) is a biopharmaceutical company that develops novel therapeutic solutions. The company offers cyclodextrin-based medicines for the treatment of neglected and orphan diseases. It also develops therapeutics for infectious diseases and lysosomal storage diseases. O …
  • Chesterton Global Ltd:企業の戦略的SWOT分析
    Chesterton Global Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Laboratoire Aguettant SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratoire Aguettant SA (Aguettant) is a pharmaceutical company that that focuses on the development, manufacturing and commercialisation of injectable hospital medicines. The company offers sterile injectable medicines in various dosages and pharmaceutical forms. It provides its products f …
  • Essilor International S.A.:企業の戦略・SWOT・財務情報
    Essilor International S.A. - Strategy, SWOT and Corporate Finance Report Summary Essilor International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Fnm Spa
    Fnm Spa - Strategy, SWOT and Corporate Finance Report Summary Fnm Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Forrester Research, Inc.:企業の戦略・SWOT・財務分析
    Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report Summary Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Enbridge Inc (ENB):企業の財務・戦略的SWOT分析
    Enbridge Inc (ENB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆